Fifty Two Week Extension Trial of Org 50081 (Esmirtazapine) in the Treatment of Insomnia (P05708)
Clinical trial NCT00610675 · COMPLETED
Trial details
- NCT number
- NCT00610675
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-07
- Primary completion
- 2009-08-17
- Enrollment
- 346
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.